Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors

Data from the St. Jude lifetime cohort study (St. Jude LIFE) revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors.

Related Keywords

Nakyla Shelton ,Daniel Mulrooney ,Yadav Sapkota ,Qi Liu ,Stephanie Dixon ,John Lucas ,Aaron Mcdonald ,Isaacb Rhea ,Leslie Robison ,Deo Kumar Srivastava ,Yutaka Yasui ,Matthew Ehrhardt ,Gregory Armstrong ,Melissa Hudson ,National Cancer Institute Center Support ,Jude Children Research Hospital ,Jude Department Of Oncology ,University Of Tennessee Health Science Center ,University Of Alberta ,Jude Children ,Research Hospital ,Jude Department ,Tennessee Health Science Center ,Kirsten Ness ,National Cancer Institute ,Cancer Center Support ,Cancer ,Heart ,Anthracycline ,Flood ,Cardiomyopathy ,Fell ,Children ,Hospital ,Muscle ,Ncology ,Research ,